Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2019-06-25 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 25, 2019, addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is an intimation or announcement about upcoming investor meetings, not a financial report or detailed presentation. The document length is only 1748 characters, indicating it is a brief announcement rather than a full report. There is no financial data, no detailed analysis, or results presented. Therefore, this document is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2019-06-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The content is about informing the exchanges of upcoming investor meetings, not about financial results, reports, or filings. The document length is short (2151 characters) and does not contain financial data or detailed report content. It is an announcement of meetings rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-06-20 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a detailed transcript of a financial results conference call for Q4 and FY19 of Dr. Lal PathLabs Limited. It includes management commentary, financial performance data, and a Q&A session with analysts. The text explicitly mentions it is a "Financial Results Conference Call Transcript" and contains detailed financial figures, operational updates, and forward-looking statements. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document length is substantial (15,000 characters), and it contains the full transcript, not just an announcement or summary. Therefore, the correct classification is CT with high confidence.
2019-06-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated June 18, 2019, addressed to stock exchanges, informing them about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of upcoming meetings with investors, not a financial report, earnings release, or detailed presentation. The document length is only 1616 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and disclosures that do not fit other specific categories.
2019-06-18 English
Acquisition
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the approval by the Board of Directors of a wholly owned subsidiary to sign a binding term sheet for acquisition of 70% equity stake in a new company. The document provides detailed information about the acquisition, including the target entity, industry, consideration, and background. It is a regulatory announcement about a capital acquisition event, not a full financial report or earnings release. The document is approximately 5312 characters, which is relatively short and focused on disclosure of a corporate event. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through acquisition.
2019-06-14 English
Related Party Transactions
Interim / Quarterly Report Classification · 95% confidence The document is a detailed disclosure of related party transactions for the half year ended March 31, 2019, including names of related parties, transactions, outstanding balances, and compensation details. It references compliance under SEBI Listing Obligations and Disclosure Requirements Regulation 23(9), which mandates disclosure of related party transactions. The content is substantive and financial in nature, covering a specific reporting period shorter than a full fiscal year (half year). It is not an announcement or a brief summary but a detailed report of financial transactions and balances. Therefore, it fits the definition of an Interim / Quarterly Report (IR), as it contains actual financial data and analysis for a period shorter than a full fiscal year. H2 2019
2019-06-12 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.